Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shepherd

Showing results (1211-1220 of 1,281) with videos related to

Pageof 129
Sort By:
Hormones & Cancer|May 4, 2016
Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast BiopsyHannah Oh, Zeina G Khodr, Mark E Sherman, et al.
Cancer Treatment and Research Communications|March 12, 2022
Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare systemKirstin Perdrizet, Tracy L Stockley, Jennifer H Law, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2023
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURAJhanelle E Gray, Myung-Ju Ahn, Geoffrey R Oxnard, et al.
Eclinicalmedicine|March 20, 2026
Reliable classification of polyps based on artificial intelligence: a development and validation studyFrida M I Julbø, Audun L Henriksen, Manohar Pradhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2018
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical OutcomesNicolas Marcoux, Scott N Gettinger, Grainne O'Kane, et al.
The New England Journal of Medicine|September 21, 2020
Osimertinib in Resected <i>EGFR</i>-Mutated Non-Small-Cell Lung CancerYi-Long Wu, Masahiro Tsuboi, Jie He, et al.
Plos One|May 4, 2023
Comprehensive review of safety in Experimental Human Pneumococcal ChallengeRyan E Robinson, Christopher Myerscough, Nengjie He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2023
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA TrialRoy S Herbst, Yi-Long Wu, Thomas John, et al.
Molecular Cancer Research : MCR|October 10, 2022
Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung CancerShideh Mirhadi, Wen Zhang, Nhu-An Pham, et al.
The Journal of Clinical Investigation|July 30, 2020
Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217Jason J Northey, Alexander S Barrett, Irene Acerbi, et al.
Pageof 129

Showing results (1211-1220 of 1,281) with videos related to

Sort By:
Pageof 129
Hormones & Cancer|May 4, 2016
Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast BiopsyHannah Oh, Zeina G Khodr, Mark E Sherman, et al.
Cancer Treatment and Research Communications|March 12, 2022
Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare systemKirstin Perdrizet, Tracy L Stockley, Jennifer H Law, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2023
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURAJhanelle E Gray, Myung-Ju Ahn, Geoffrey R Oxnard, et al.
Eclinicalmedicine|March 20, 2026
Reliable classification of polyps based on artificial intelligence: a development and validation studyFrida M I Julbø, Audun L Henriksen, Manohar Pradhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2018
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical OutcomesNicolas Marcoux, Scott N Gettinger, Grainne O'Kane, et al.
The New England Journal of Medicine|September 21, 2020
Osimertinib in Resected <i>EGFR</i>-Mutated Non-Small-Cell Lung CancerYi-Long Wu, Masahiro Tsuboi, Jie He, et al.
Plos One|May 4, 2023
Comprehensive review of safety in Experimental Human Pneumococcal ChallengeRyan E Robinson, Christopher Myerscough, Nengjie He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2023
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA TrialRoy S Herbst, Yi-Long Wu, Thomas John, et al.
Molecular Cancer Research : MCR|October 10, 2022
Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung CancerShideh Mirhadi, Wen Zhang, Nhu-An Pham, et al.
The Journal of Clinical Investigation|July 30, 2020
Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217Jason J Northey, Alexander S Barrett, Irene Acerbi, et al.
Pageof 129